What is the ticker symbol for Atea Pharmaceuticals?

Atea Pharmaceuticals trades under the ticker AVIR on NASDAQ.

What sector does Atea Pharmaceuticals operate in?

Atea Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AVIR in a portfolio?

PortView shows AVIR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Atea Pharmaceuticals (AVIR) Stock Analysis

NASDAQHealthcareBiotechnology

$4.23+1.55%

1-year price historyRange $2.96 – $6.15

52-week range$4.23

$2.87$6.45

Track AVIR in your portfolio for free · Portfolio tracker

What Atea Pharmaceuticals does

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Key metrics

Market cap

$339.63M

P/E (TTM)

-2.01

EPS (TTM)

$-2.11

Beta

0.28

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$5.11

200-day avg

$4.92

52-week high

$6.45

52-week low

$2.87

CEO

Jean-Pierre Sommadossi

ETFs linked to AVIR

Broad-market and Healthcare sector ETFs an investor holding Atea Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AVIR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AVIR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Atea Pharmaceuticals?: Atea Pharmaceuticals trades under the ticker AVIR on NASDAQ.
Which exchange is AVIR listed on?: AVIR is listed on NASDAQ.
What sector does Atea Pharmaceuticals operate in?: Atea Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AVIR in a portfolio?: PortView shows AVIR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.